GC Therapeutics

We're #hiring a new Research Associate - Molecular Biology in Cambridge, Massachusetts. Apply today or share this post with your network.

We’re excited to share that our CEO, Parastoo Khoshakhlagh, Ph.D., a 2023 Termeer Fellow will be a featured panelist at an upcoming discussion on female leaders in biotech hosted by The Termeer Foundation and WEST - Women in the Enterprise of Science and Technology. This panel will explore the unique experiences, challenges, and successes of women stepping into leadership roles as executives and founders in the biotech industry. Parastoo will be joined by fellow inspiring female leaders Vered Bisker-Leib, Nele Van Dessel (Termeer Fellow), and Jo Viney. Special thanks to Rachele Ryan, Director of Partnerships at LabCentral for moderating! 📅 Date: November 6, 2024 🕒 Time: 8:00-10:00 AM ET 📍 Location: The Termeer Foundation, 1393 Boylston St., Boston, MA 02215 🔗 Learn more and register at https://lnkd.in/gUSNvzcm Join us for an empowering conversation that aims to uplift and celebrate women making waves in the world of biotech!

Thrilled to have attended BioFuture for the third consecutive year! Last week, at the Cure. in New York City, #BioFuture 2024 gathered a remarkable community of trailblazers, disruptors, and investors from across the healthcare ecosystem to discuss the future of healthcare innovation. The conference spotlighted impactful discussions on AI/ML, quantum computing, policy advancements, neuroscience, oncology, obesity treatments, longevity, biomanufacturing, cell and gene therapy, cardiovascular health, women’s health, and financing strategies. We explored the convergence of deep tech and deep science in drug discovery & development, diving into the forefront of healthcare transformation. It was also the perfect opportunity to reconnect with fellow investors, founders, and ecosystem partners. Great to finally meet Parastoo Khoshakhlagh, Ph.D. in person and catch up with Tingting Zhang-Kharas, PhD, Silvia Garcia Codony, and Lynda Chin. A huge thanks to Sara Jane Demy and Demy-Colton for organizing such an inspiring event. Already looking forward to BioFuture 2025! #healthcare #biotech #lifescience #biopharma #TechBio #AI #Therapeutics #venturecapital #innovations #deeptech

Proud to announce that our CEO Parastoo Khoshakhlagh, Ph.D. will be speaking on the panel Emerging Technologies and Approaches in Cell & Gene Therapy at #BioFuture2024! With the field evolving at an incredible pace, emerging technologies like AI and machine learning are reshaping what we can achieve. She will be joined by Paul Bresge, Kate Rochlin, PhD and moderator Lei Lei Wu to discuss how these innovations are breaking through current limitations, enhancing precision, and speeding up the journey from research to real-world applications. Together, we're making strides toward more effective, accessible therapies that have the power to transform lives. Special thank you to Sara Jane Demy, Sara Pinto, and Kimberly Ha for the invitation and opportunity contribute to the discussion and explore the latest topics shaping the future of #healthcare. Join us for insightful conversations driving the next wave of breakthrough innovation. Register at www.BioFuture.com!

Will you be attending the 5th Cell Therapies and Immunotherapy Conference in San Diego hosted by AIChE - American Institute of Chemical Engineers? If you are, be sure to check out our company presentation with Dr. Cory Smith, our Head of Discovery Platforms & Scientific Co-Founder, on October 28th from 3:20-4:10pm PT during the Poster Lightning Talks session! For more info: https://bit.ly/3YJnBtC

We're #hiring a new Scientist/Senior Scientist - Computational Biologist in Cambridge, Massachusetts. Apply today or share this post with your network.

Our CEO Parastoo Khoshakhlagh, Ph.D. is grateful to have had the opportunity to join the 2024 Precision Health Summit and speak on a panel about Ensuring Equitable Access to Precision Regenerative Medicine. It was a pleasure to connect with such a talented group of professionals, including Dr. Peter Marks, Dr. Brigitte Arduini, and Willie T. Reaves Jr. and to be given the platform to share these insights. Thank you to 1BusinessWorld , the organizers, fellow panelists, and everyone who attended! We are looking forward to more opportunities to engage and learn together.

Our mission at GC Therapeutics is rooted in the grand vision of our co-founder and advisor, Prof. George Church: creating higher-quality cell therapies that are accessible to all patients. This mission aligns closely with Henri Termeer’s legacy. We are dedicated to fulfilling our responsibility as a biotech company, as Henri described—to tackle what seems impossible and make a real difference for patients. As a #Termeer Fellow I am grateful for the opportunity to work alongside mentors and colleagues who share the same passion as we do at GC Therapeutics. This collective support has significantly helped me do my job better. I am incredibly proud and thankful to be part of this amazing community!

"It’s our responsibility to do what seems impossible if we can make a difference to patients.” - Henri Termeer GCTx is committed to live Henri Termeer’s legacy. Our CEO, Parastoo Khoshakhlagh, Ph.D. has been a The Termeer Foundation fellow since 2023 and is grateful for the recognition!

"Also last month, famed synthetic biology pioneer George Church announced a new startup that raised $75 million for a cell therapy platform that aims to deliver off-the-shelf #iPSC medicines up to 100 times faster than conventional methods, using a four-day process. Called GC Therapeutics, it is aptly named because Church himself donated his own skin cells to reprogram into the stem cells used by the platform." Great to have our technology at GC Therapeutics mentioned by Forbes